Literature DB >> 27523008

Malignant Hypertension with Thrombotic Microangiopathy.

Hayato Mitaka1, Yuji Yamada, Osamu Hamada, Shintaro Kosaka, Naoki Fujiwara, Yoshitaka Miyakawa.   

Abstract

A 49-year-old man with malignant hypertension, acute kidney injury and mental deterioration was referred to our hospital. We initially observed microangiopathic hemolytic anemia, thrombocytopenia and kidney damage, indicating he had thrombotic microangiopathy (TMA). We considered TMA was caused by malignant hypertension and therefore did not start plasma therapy. The French TMA reference center reported that platelet counts and serum creatine levels have high values for predicting severe ADAMTS13 deficiency. The patient fully recovered from his illness after treatment with antihypertensive drugs and intermittent hemodialysis. This case might thus be useful to understand the proper differential diagnosis and treatment of TMA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27523008     DOI: 10.2169/internalmedicine.55.6332

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Diffuse Alveolar Hemorrhaging with Hypertensive Emergency: A Rare but Important Cause of Hemoptysis.

Authors:  Ayana Suzuki; Naoki Nakagawa; Keisuke Maruyama; Motoki Matsuki; Naoyuki Hasebe
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

2.  Thrombotic Microangiopathy Due to Malignant Hypertension Treated Exclusively With Antihypertensive Therapy.

Authors:  Taro Asano; Hideki Mori
Journal:  Cureus       Date:  2022-02-02

3.  A rare case of malignant hypertension with splenic rupture and thrombotic microangiopathy: A case report.

Authors:  JiaXiang Ding; Zhen Qu; Feng Yu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.